Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression
– Funding to advance development of miniature implantable stimulator to unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders. January 24, 2024 09:00 AM Eastern Standard Time HOUSTON–(BUSINESS WIRE)–Motif Neurotech, a neurotechnology company developing minimally-invasive bioelectronics…